Second-quarter earnings season is in full swing, and the results have been largely resilient so far. So why are stocks ...

Earnings jumped to $1.03 a share, up from $0.60 a year ago, as Emerson ( NYSE: EMR) improved its pretax margin by 570 basis ...

This would indicate a 6% year-over-year growth in earnings and a 3% increase in sales when compared to the previous year’s ...

Advanced Micro Devices, Super Micro, Palantir, and others reported earnings the last week. Here's what the numbers are telling investors.

Novo Nordisk reported second quarter earnings a week after revising its 2025 outlook down on slower GLP-1 sales.

On a per-share basis, the Palo Alto, California-based company said it had net income of $2.39. Earnings, adjusted to account for discontinued operations, came to $2.26 per share. The results surpassed ...

Pfizer ( PFE) reported a beat in second quarter earnings Tuesday, and reaffirmed its 2025 guidance of between $61 to $64 ...

Q2 2025 Management View Dave Cramer, President and CEO, reported sequential improvement in occupancy and contract rates, but ...

Over the last five years, the stock has decreased in 56% of these instances, with a median decline of -3.1% and a maximum ...

Q3 2025 Management View Stephen D. Westhoven, President and CEO, indicated, "Fiscal 2025 continues to be an excellent year ...

Earnings per share is one of the best metrics of a company’s financial health. In this guide, Benzinga discusses the ins and outs of earnings per share (EPS).

Earnings per share is the amount of net income you make per share of a stock within a given time period. In other words, it defines how well a stock is performing in the current market.